Ultra Market Research | Global eClinical Solutions
Global eClinical Solutions
Report ID : 925
Category : Medical-Devices
No Of Pages : 110
Published on: January 2025
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Global eClinical Solutions Market
Introduction
The Global eClinical Solutions Market is related to innovative technologies and software solutions that enhance the clinical trial processes, ensuring the accuracy and efficiency of data. It integrates advanced analytics, data management, and cloud-based platforms to facilitate a streamlined clinical research workflow. Its applications range from pharmaceuticals to biotechnology and clinical research organizations, with key benefits including reduced costs for trials and enhanced decision-making capabilities. The latest trends observed are the introduction of artificial intelligence in predictive analytics, wearable devices for real-time data collection, and decentralized trials to reach broader patients. The market size is likely to exceed more than USD 15 billion by 2025. The growth factor includes increasing investments in R&D, regulatory requirements, and increasing demand for more efficient clinical trials.
Segmentation
Technology Type
Electronic Data Capture (EDC)
Cloud-Based EDC
On-Premise EDC
Others
Clinical Trial Management Systems (CTMS)
Site Management
Study Planning
eCOA (Electronic Clinical Outcome Assessment)
Patient-Reported Outcomes (PROs)
Clinician-Reported Outcomes (ClinROs)
Others
Randomization and Trial Supply Management (RTSM)
Safety Solutions
Delivery Mode
Web-Based
Subscription-Based
Customizable Platforms
Cloud-Based
Public Cloud
Private Cloud
Others
Hybrid Solutions
End-User
Pharmaceutical Companies
Large Enterprises
SMEs
Biotechnology Firms
Research-Driven
Application-Specific
Contract Research Organizations (CROs)
Global CROs
Regional CROs
Others
Academic Institutions
Regulatory Bodies
Clinical Trial Phase
Phase I
Early-Stage Research
Safety Studies
Phase II
Efficacy Studies
Dosage Optimization
Phase III
Large-Scale Trials
Multicentric Studies
Phase IV
Post-Marketing Surveillance
Real-World Evidence
Market Players
Medidata Solutions (USA)
Oracle Corporation (USA)
Parexel International (USA)
Veeva Systems (USA)
BioClinica (USA)
IBM Watson Health (USA)
CRF Health (Finland)
eClinicalWorks (USA)
ERT (USA)
ArisGlobal (USA)
DataTrial (UK)
Medrio (USA)
OmniComm Systems (USA)
ICON Plc (Ireland)
Clario (USA)
Drivers
The market is driven by the complexity of clinical trials, requiring sophisticated data management solutions. The increase in R&D expenditure, along with the growing prevalence of chronic diseases, necessitates innovative solutions to speed up drug development. Regulatory bodies encourage the adoption of eClinical technologies to ensure data accuracy and compliance. The push for decentralized trials post-pandemic and advancements in AI-driven analytics also drive adoption. Emerging markets in Asia-Pacific are also promising due to increasing investments in healthcare infrastructure and clinical research.
Restraints
Challenges include the high initial cost of implementation, which deters smaller organizations. There is also a lack of awareness about eClinical technologies in developing regions, and data security and privacy concerns hinder market growth. Integration complexities with existing systems and stringent regulatory frameworks further add to the problem. The absence of standardization across platforms and traditional clinical research entities' reluctance to shift to digital methods also slows down adoption.
Opportunity
This has massive opportunities in wearable devices and real-time monitoring solutions. Extensive applications of AI and ML in data analytics would provide a prediction of a trial's likely outcome. Other potential markets also emerge in the form of clinical trial outsourcing that can be developed through Asia-Pacific and Latin American emerging markets. It also facilitates joint ventures with CROs that can facilitate eClinical custom solution requirements for every individual trial requirement.
Trend
Decentralized clinical trials, in particular, have become one of the primary trends, permitting remote participation while increasing patient heterogeneity. Incorporation of AI and machine learning drives smarter designs for trials; predictive modeling outcomes are ensured by these technologies. Blockchain technology pertaining to secure data sharing and transparency has gained momentum. More importantly, SaaS-based post-market surveillance uses real-world evidence (RWE) data generated from electronic health records (EHRs) and wearables. SaaS-based solutions will continue to remain the norm owing to their ability to scale easily and cost efficiency.
Approved Products and Pipeline
Medidata Rave EDC
Oracle Health Sciences Cloud
Veeva Vault eTMF
Clario’s Digital Biomarkers
IBM Clinical Development Platform
BioClinica’s SMART Technology Suite
Key Target Audience
Pharmaceutical Companies
Biotechnology Firms
CROs
Academic Research Institutions
Healthcare Regulatory Authorities
Technology Vendors
Investors and Venture Capitalists
Frequently Asked Questions (FAQ’s)
It refers to software and technologies that enhance clinical trial processes, including data management and analytics.
Growing R&D investments, the need for efficient trials, and advancements in AI and decentralized trials.
High costs, data security concerns, and integration challenges.
North America leads, followed by Europe and the rapidly growing Asia-Pacific region.
Medidata, Oracle, Parexel, Veeva, and others are significant contributors.
Global eClinical Solutions Market 2024
Table of Contents
1. Introduction
1.1 Report Description 1.2 Research Methodology 1.2.1 Data Mining 1.2.2 Market Modeling and Forecasting 1.2.3 Data Validation 1.2.4 Industry Analysis
2. Market Dashboard
3. Market Overview
3.1 Market Definition and Scope 3.2 Market Segmentation 3.2.1 By Treatment Type 3.2.2 By Patient Demographics 3.2.3 By Distribution Channels 3.2.4 By Therapeutic Applications 3.2.5 By Geography 3.3 Market Dynamics 3.3.1 Drivers 3.3.2 Restraints 3.3.3 Opportunities 3.3.4 Challenges
4. Global eClinical Solutions Market by Treatment Type
4.1 Introduction 4.2 Market Size and Growth Rate by Treatment Type (2024-2030) 4.2.1 Chemotherapy
Induction Phase
Consolidation Phase
Maintenance Phase 4.2.2 Targeted Therapies
Tyrosine Kinase Inhibitors
Antibody-Drug Conjugates
Others 4.2.3 Immunotherapies
CAR-T Therapy
Monoclonal Antibodies
5. Global eClinical Solutions Market by Patient Demographics
5.1 Introduction 5.2 Market Size and Growth Rate by Patient Demographics (2024-2030) 5.2.1 Children
Infants
Toddlers and Young Children 5.2.2 Adults
Young Adults
Seniors
6. Global eClinical Solutions Market by Distribution Channels
6.1 Introduction 6.2 Market Size and Growth Rate by Distribution Channel (2024-2030) 6.2.1 Hospital Pharmacies
Tertiary Care Centers
Pediatric Oncology Units 6.2.2 Retail Pharmacies
Local Pharmacies
Chain Pharmacies 6.2.3 Online Pharmacies
7. Global eClinical Solutions Market by Therapeutic Applications
7.1 Introduction 7.2 Market Size and Growth Rate by Therapeutic Applications (2024-2030) 7.2.1 First-Line Treatment
Chemotherapy-Only Regimens
Targeted Therapies 7.2.2 Relapse or Refractory ALL
CAR-T Therapies
Experimental Treatments
8. Global eClinical Solutions Market by Geography
8.1 Introduction 8.2 Market Size and Growth Rate by Region (2024-2030) 8.2.1 North America
United States
Canada 8.2.2 Europe
Germany
France
United Kingdom
Rest of Europe 8.2.3 Asia Pacific
China
Japan
India
Southeast Asia
Rest of Asia Pacific 8.2.4 Latin America
Brazil
Rest of Latin America 8.2.5 Middle East & Africa (MEA)
GCC
North Africa
South Africa
Rest of Middle East & Africa
9. Competitive Landscape
9.1 Company Profiles 9.1.1 Amgen Inc. (United States)
Business Overview
Product Portfolio
Strategic Developments
Financial Overview 9.1.2 Novartis AG (Switzerland)
Business Overview
Product Portfolio
Strategic Developments
Financial Overview 9.1.3 Pfizer Inc. (United States)
Financial Overview 9.1.15 Eli Lilly and Company (United States)
Business Overview
Product Portfolio
Strategic Developments
Financial Overview
10.List of Tables and Figures
Table 1: Global Market Size by Treatment Type (2024-2030)
Table 2: Regional Market Share by Geography
Table 3: Key Players and Strategic Developments
Figure 1: Market Dynamics Overview
Figure 2: Treatment Adoption by Patient Demographics
Figure 3: Market Trends and Forecasts (2024-2030)
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done, and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Global eClinical Solutions Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Global eClinical Solutions Market for the past year and forecasts for the next six years. Global eClinical Solutions Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different Global eClinical Solutions Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for Global eClinical Solutions Market from different application industries in different regions.
